James Graydon is a Manager in Clinical Pharmacology and Quantitative Pharmacology at AstraZeneca, where they focus on leveraging science-informed data analysis to enhance clinical programs. With a background in molecular biology, James has provided operational and strategic support for clinical trials and was previously a Manager of Nonclinical, Clinical, and Quantitative Pharmacology at Alexion Pharmaceuticals. Their experience includes roles as a Scientist II/Analyst at Syntimmune and a Clinical Laboratory Technologist at Genomas Inc. James holds a Bachelor of Science in Biochemistry from Trinity College-Hartford, where they also completed an undergraduate research assistantship. Patient centricity deeply influences James's work and commitment to developing effective therapeutics.
Location
New York, United States
This person is not in the org chart
This person is not in any teams
This person is not in any offices